These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 479760)

  • 1. Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody.
    Patrick Sissons JG; Schreiber RD; Perrin LH; Cooper NR; Müller-Eberhard HJ; Oldstone MB
    J Exp Med; 1979 Sep; 150(3):445-54. PubMed ID: 479760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.
    Sissons JG; Oldstone MB; Schreiber RD
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):559-62. PubMed ID: 6928644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.
    Perrin LH; Joseph BS; Cooper NR; Oldstone MB
    J Exp Med; 1976 May; 143(5):1027-41. PubMed ID: 177712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative complement pathway-mediated lysis of measles virus infected cells: induction by IgG antibody bound to individual viral glycoproteins and comparative efficacy of F(ab')2 and Fab' fragments.
    Sissons JG; Cooper NR; Oldstone MB
    J Immunol; 1979 Nov; 123(5):2144-9. PubMed ID: 489977
    [No Abstract]   [Full Text] [Related]  

  • 5. Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins.
    Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1978 Dec; 148(6):1722-7. PubMed ID: 722244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles.
    Hicks JT; Klutch MJ; Albrecht P; Frank MM
    J Immunol; 1976 Jul; 117(1):208-15. PubMed ID: 819582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway.
    Joseph BS; Cooper NR; Oldstone MB
    J Exp Med; 1975 Apr; 141(4):761-74. PubMed ID: 1092789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate pathways of C activation by measles virus cytotoxic antibodies: subclass analysis and capacity of F(ab) molecules to activate C via the alternative pathway.
    Ehrnst A
    J Immunol; 1978 Sep; 121(3):1206-12. PubMed ID: 690438
    [No Abstract]   [Full Text] [Related]  

  • 11. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.
    Mold C; Nemerow GR; Bradt BM; Cooper NR
    J Immunol; 1988 Mar; 140(6):1923-9. PubMed ID: 2831273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How immune complexes from certain IgG NAbs and any F(ab')₂ can mediate excessive complement activation.
    Lutz HU
    Adv Exp Med Biol; 2012; 750():186-96. PubMed ID: 22903675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
    Beebe DP; Schreiber RD; Cooper NR
    J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule.
    Jarvis GA; Griffiss JM
    J Immunol; 1991 Sep; 147(6):1962-7. PubMed ID: 1909736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350.
    Mold C; Bradt BM; Nemerow GR; Cooper NR
    J Immunol; 1988 Jun; 140(11):3867-74. PubMed ID: 2836501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement.
    Schreiber RD; Pangburn MK; Medicus RG; Müller-Eberhard HJ
    Clin Immunol Immunopathol; 1980 Mar; 15(3):384-96. PubMed ID: 6899978
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of antibody and complement in lysing virus-infected cells.
    Sissons JG; Schreiber RD; Cooper NR; Oldstone MB
    Med Microbiol Immunol; 1982; 170(4):221-7. PubMed ID: 7048046
    [No Abstract]   [Full Text] [Related]  

  • 18. Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading.
    Sundsmo JS; Götze O
    J Exp Med; 1981 Sep; 154(3):763-77. PubMed ID: 6912276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of immune precipitation by purified components of the alternative pathway.
    Naama JK; Holme E; Hamilton E; Whaley K
    Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    Medicus RG; Götze O; Müller-Eberhard HJ
    J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.